| Year | IPO | M&A | Repurchase | Liquidation | New OTC |
| 2006 | 491.45 | 27.35 | −30.81 | −53.63 | - |
| 2007 | 436.07 | −15.37 | −26.80 | −42.63 | - |
| 2008 | 916.66 | 28.35 | −41.98 | −29.13 | - |
| 2009 | 327.75 | 4.74 | −29.47 | −42.66 | - |
| 2010 | 736.68 | 44.71 | −21.19 | −24.43 | 48.85 |
| 2011 | 799.38 | 41.47 | −30.51 | −65.37 | 63.19 |
| 2012 | 486.10 | 198.29 | 29.18 | −15.34 | 32.48 |
| 2013 | 448.03 | 15.27 | −34.28 | −43.47 | 89.79 |
| 2014 | 601.66 | 63.55 | −34.43 | −34.43 | 27.26 |
| 2015 | 779.27 | 135.55 | 19.01 | −15.60 | 16.86 |
| 2016 | 922.12 | 323.41 | 3.02 | −43.62 | 193.82 |
| Average | 631.38 | 78.85 | −18.02 | −37.30 | 67.46 |